Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Watson_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2012
|
| gptkbp:foundedBy |
gptkb:Robert_Wessman
|
| gptkbp:foundedYear |
1999
|
| gptkbp:headquartersLocation |
gptkb:Iceland
gptkb:Reykjavík |
| https://www.w3.org/2000/01/rdf-schema#label |
Actavis Group
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Sigurdur_Oli_Olafsson
gptkb:Robert_Wessman |
| gptkbp:mergedInto |
gptkb:Allergan
|
| gptkbp:notableEvent |
rebranded as Allergan in 2015
|
| gptkbp:notableProduct |
generic Adderall
generic Concerta |
| gptkbp:numberOfEmployees |
~10,000 (at peak)
|
| gptkbp:operatesIn |
gptkb:Asia
gptkb:Europe gptkb:United_States |
| gptkbp:products |
generic drugs
branded pharmaceuticals |
| gptkbp:stockExchange |
gptkb:Iceland_Stock_Exchange_(delisted)
|
| gptkbp:website |
www.actavis.com
|
| gptkbp:bfsParent |
gptkb:Watson_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|